Skip to main content
. 2016 Feb 29;6:22287. doi: 10.1038/srep22287

Table 2. Fold changes (relative intensity) in the abundance of metabolites detected in the LPS-deficient polymyxin-resistant 19606R, relative to the parent strain ATCC 19606.

Formula Putative metabolitea Pathway/metabolism Fold change P-value
Carbohydrate
 C5H12O5 Xylitol Pentose and glucoronate interconversions 3.47 0.00017
 C12H23O14P Lactose 6-phosphate Galactose metabolism 2.14 0.0018
 C3H6O9P2 Cyclic 2,3-bisphospho-D-glycerate Carbohydrate metabolism –3.01 0.0035
Amino acids
 C7H11O8P Shikimate 3-phosphate Phenylalanine, tyrosine, tryptophan biosynthesis 14.41 0.0012
 C10H13O10P 5-O-(1-Carboxyvinyl)-3-phosphoshikimate Phenylalanine, tyrosine, tryptophan biosynthesis 11.30 0.0079
 C8H8O5 3,4-Dihydroxymandelate Tyrosine 3.03 0.00074
 C4H6O3 2-Methyl-3-oxopropanoate Valine, leucine and isoleucine degradation 2.19 0.00060
 C2H5O5P Acetyl phosphate Taurine and hypotaurine 2.15 9.2E-05
 C9H8O3 Phenylpyruvate Phenylalanine –2.00 5.9E-05
 C9H10O4 3-(2,3-Dihydroxyphenyl)propanoate Phenylalanine –2.03 0.0011
 C13H15NO6 4-Hydroxyphenylacetylglutamic acid Tyrosine –2.08 0.0077
 C7H15NO3 L-Carnitine Lysine degradation –2.57 0.00049
 C6H6N2O2 Urocanate Histidine –3.75 0.0031
 C6H10N2O4 N-Formimino-L-glutamate Histidine –24.86 0.00095

aPutative metabolites, identified by exact mass, with at least 2-fold differences at p value < 0.01 between the polymyxin-resistant 19606R and the polymyxin-susceptible ATCC 19606.

HHS Vulnerability Disclosure